HSIC 130.31 Henry Schein $HSIC Hit a 52 week high
Post# of 46
Posted On: 11/06/2014 11:17:57 PM
HSIC 130.31 Henry Schein $HSIC Hit a 52 week high of 133.16 Closing the day 11/06/14 at 130.31 +8.10 +6.63% With a day low of 122.22 and a total volume of 1,998,918.
HSIC Recent Posts: http://investorshangout.com/Henry-Schein-HSIC-54374/
HSIC Henry Schein Recent Headline News
Henry Schein
at Investor's Business Daily - Thu Nov 06, 5:49PM CST
Henry Schein (HSIC) Q3 earnings rose 9.8% to $1.34 a share, topping by 4 cents, and revenue edged up 11.7% to $2.62 bil, topping views for $2.55 bil. Shares of the health care product company rose 6.6% to 130.31.
HSIC: 130.31 (+8.10)
After Yesterday's Rally of 6.63% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Nov 06, 4:06PM CST
Henry Schein (NASDAQ:HSIC) traded in a range yesterday that spanned from a low of $122.22 to a high of $133.16. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high of $122.83 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSIC: 130.31 (+8.10)
Henry Schein Set to Possibly Pullback After Yesterday's Rally of 6.63%
Comtex SmarTrend(R) - Thu Nov 06, 4:05PM CST
Henry Schein (NASDAQ:HSIC) traded in a range yesterday that spanned from a low of $122.22 to a high of $133.16. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high of $122.83 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSIC: 130.31 (+8.10)
Henry Schein beats Street 3Q forecasts
Automated Insights - Thu Nov 06, 6:30AM CST
MELVILLE, N.Y. (AP) _ Henry Schein Inc. (HSIC) on Thursday reported third-quarter net income of $114.8 million.
HSIC: 130.31 (+8.10)
Henry Schein Reports Record Third Quarter Results
PR Newswire - Thu Nov 06, 6:00AM CST
Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reported record financial results for the quarter ended September 27, 2014.
HSIC: 130.31 (+8.10)
What's in Store for TrovaGene (TROV) This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 2:40PM CST
TrovaGene Inc. (TROV) is set to report third-quarter 2014 results on Nov 6.
MACK: 8.77 (+0.42), TROV: 4.62 (-0.12), PTCT: 42.17 (+3.20), HSIC: 130.31 (+8.10)
The Dr. Edward B. Shils Entrepreneurial Fund Recognizes Outstanding Innovators In Dentistry
PR Newswire - Tue Nov 04, 10:10AM CST
The Dr. Edward B. Shils Entrepreneurial Fund, Inc., a non-profit organization dedicated to innovative leadership in health care and named after the late Dr. Edward B. Shils, announced today the recipients of the 2014 Shils Awards. The Awards, which recognize individuals, organizations and programs that positively influence the dental community and the public oral health arena, were presented at the Shils Fund Dinner, held Oct. 29, at the Union League of Philadelphia in Philadelphia, Pa. Click here for photos of Award winners
HSIC: 130.31 (+8.10)
Henry Schein Larger Than S&P 500 Component Ralph Lauren
TheOnlineInvestor.com - Mon Nov 03, 3:52PM CST
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Henry Schein, Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example Ralph Lauren Corp , according to The...
HSIC: 130.31 (+8.10)
Will CVS Health (CVS) Keep its Earnings Streak Alive in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 2:30PM CST
CVS Health Corporation (CVS) is scheduled to report its third-quarter 2014 results before the opening bell on Nov 4.
AMSG: 51.34 (-0.03), CFN: 57.44 (+0.03), CVS: 88.43 (+0.93), HSIC: 130.31 (+8.10)
Will Covidien (COV) Disappoint Earnings Estimates in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 2:00PM CST
Covidien plc (COV) is set to report fourth-quarter fiscal 2014 results on Nov 5.
ACT: 250.38 (+2.47), MDT: 68.74 (+0.04), COV: 92.60 (-0.72), HSIC: 130.31 (+8.10)
Will Becton, Dickinson (BDX) Beat Q4 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 3:53PM CDT
Becton, Dickinson and Company (BDX) is set to report fourth-quarter fiscal 2014 results on Nov 4.
BDX: 127.93 (+0.71), ALNY: 92.91 (+4.90), PTN: 0.78 (-0.01), HSIC: 130.31 (+8.10)
Will TripAdvisor (TRIP) Beat Q3 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 3:45PM CDT
We expect online travel research company TripAdvisor Inc. (TRIP) to beat expectations when it reports the third-quarter 2014 results on Nov 4.
AMSG: 51.34 (-0.03), TRIP: 74.00 (+2.05), SPR: 40.71 (+0.20), HSIC: 130.31 (+8.10)
Will Priceline.com (PCLN) Disappoint this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 3:44PM CDT
Priceline.com Inc. (PCLN) is set to report the third-quarter 2014 results on Nov 4. Last quarter, the company posted 4.5% positive surprise. Let's see how things are shaping up for this announcement.
AMSG: 51.34 (-0.03), SPR: 40.71 (+0.20), HSIC: 130.31 (+8.10), PCLN: 1,097.75 (+2.41)
Henry Schein's Think Pink, Practice Pink Program Donates More Than $173,000 To Organizations Supporting Cancer-Related Causes In 2014
PR Newswire - Fri Oct 31, 6:00AM CDT
Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today that its "Think Pink, Practice Pink" cause-related marketing program has contributed more than $173,000 to cancer-related causes in 2014.
HSIC: 130.31 (+8.10)
DENTSPLY (XRAY) Beats Q3 Earnings, Misses on Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 3:30PM CDT
DENTSPLY International Inc. (XRAY) reported third-quarter 2014 adjusted earnings of 62 cents per share, which beat the Zacks Consensus Estimate by a couple of cents.
BRLI: 29.19 (-0.23), STE: 62.98 (+0.32), HSIC: 130.31 (+8.10), XRAY: 52.13 (+0.51)
Tornier N.V. (TRNX) Jumps: Stock Moves 7.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 8:46AM CDT
Tornier N.V. (TRNX) was a big mover last session, with shares rising nearly 8% on the day.
CAH: 79.60 (+0.69), TRNX: 25.59 (-0.69), HSIC: 130.31 (+8.10), COO: 166.08 (+1.78)
Heska Signs Distribution Agreement with Henry Schein Animal Health
PR Newswire - Wed Oct 29, 7:45AM CDT
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"
, a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today a new distribution agreement with Henry Schein Animal Health, the largest companion animal health distribution company in the U.S. Henry Schein Animal Health will market and promote Heska's full line of hematology and chemistry instruments and affiliated consumables, effective immediately.
HSKA: 15.19 (+0.69), HSIC: 130.31 (+8.10)
Will Cardinal Health (CAH) Disappoint Earnings in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 5:10PM CDT
Our proven model does not conclusively show that Cardinal Health Inc. (CAH) is likely to beat earnings this quarter.
DSCI: 9.00 (+0.05), CAH: 79.60 (+0.69), HTWR: 76.66 (-0.68), HSIC: 130.31 (+8.10)
Will PerkinElmer (PKI) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 4:59PM CDT
PerkinElmer (PKI) has managed to perform decently across several product lines and also posted solid operating results in the previous quarter.
HTWR: 76.66 (-0.68), CRL: 63.73 (+1.05), HSIC: 130.31 (+8.10), PKI: 44.66 (+0.59)
LabCorp Outshines Earnings, Revenues in Q3; Guides Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:30PM CDT
Laboratory Corporation of America Holdings (LH) reported third-quarter 2014 adjusted earnings per share (EPS) of $1.80.
CAH: 79.60 (+0.69), DGX: 62.76 (+2.32), LH: 102.93 (+0.72), HSIC: 130.31 (+8.10)
HSIC Recent Posts: http://investorshangout.com/Henry-Schein-HSIC-54374/
HSIC Henry Schein Recent Headline News
Henry Schein
at Investor's Business Daily - Thu Nov 06, 5:49PM CST
Henry Schein (HSIC) Q3 earnings rose 9.8% to $1.34 a share, topping by 4 cents, and revenue edged up 11.7% to $2.62 bil, topping views for $2.55 bil. Shares of the health care product company rose 6.6% to 130.31.
HSIC: 130.31 (+8.10)
After Yesterday's Rally of 6.63% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Nov 06, 4:06PM CST
Henry Schein (NASDAQ:HSIC) traded in a range yesterday that spanned from a low of $122.22 to a high of $133.16. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high of $122.83 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSIC: 130.31 (+8.10)
Henry Schein Set to Possibly Pullback After Yesterday's Rally of 6.63%
Comtex SmarTrend(R) - Thu Nov 06, 4:05PM CST
Henry Schein (NASDAQ:HSIC) traded in a range yesterday that spanned from a low of $122.22 to a high of $133.16. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high of $122.83 on volume of 1.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSIC: 130.31 (+8.10)
Henry Schein beats Street 3Q forecasts
Automated Insights - Thu Nov 06, 6:30AM CST
MELVILLE, N.Y. (AP) _ Henry Schein Inc. (HSIC) on Thursday reported third-quarter net income of $114.8 million.
HSIC: 130.31 (+8.10)
Henry Schein Reports Record Third Quarter Results
PR Newswire - Thu Nov 06, 6:00AM CST
Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reported record financial results for the quarter ended September 27, 2014.
HSIC: 130.31 (+8.10)
What's in Store for TrovaGene (TROV) This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 2:40PM CST
TrovaGene Inc. (TROV) is set to report third-quarter 2014 results on Nov 6.
MACK: 8.77 (+0.42), TROV: 4.62 (-0.12), PTCT: 42.17 (+3.20), HSIC: 130.31 (+8.10)
The Dr. Edward B. Shils Entrepreneurial Fund Recognizes Outstanding Innovators In Dentistry
PR Newswire - Tue Nov 04, 10:10AM CST
The Dr. Edward B. Shils Entrepreneurial Fund, Inc., a non-profit organization dedicated to innovative leadership in health care and named after the late Dr. Edward B. Shils, announced today the recipients of the 2014 Shils Awards. The Awards, which recognize individuals, organizations and programs that positively influence the dental community and the public oral health arena, were presented at the Shils Fund Dinner, held Oct. 29, at the Union League of Philadelphia in Philadelphia, Pa. Click here for photos of Award winners
HSIC: 130.31 (+8.10)
Henry Schein Larger Than S&P 500 Component Ralph Lauren
TheOnlineInvestor.com - Mon Nov 03, 3:52PM CST
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Henry Schein, Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example Ralph Lauren Corp , according to The...
HSIC: 130.31 (+8.10)
Will CVS Health (CVS) Keep its Earnings Streak Alive in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 2:30PM CST
CVS Health Corporation (CVS) is scheduled to report its third-quarter 2014 results before the opening bell on Nov 4.
AMSG: 51.34 (-0.03), CFN: 57.44 (+0.03), CVS: 88.43 (+0.93), HSIC: 130.31 (+8.10)
Will Covidien (COV) Disappoint Earnings Estimates in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 2:00PM CST
Covidien plc (COV) is set to report fourth-quarter fiscal 2014 results on Nov 5.
ACT: 250.38 (+2.47), MDT: 68.74 (+0.04), COV: 92.60 (-0.72), HSIC: 130.31 (+8.10)
Will Becton, Dickinson (BDX) Beat Q4 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 3:53PM CDT
Becton, Dickinson and Company (BDX) is set to report fourth-quarter fiscal 2014 results on Nov 4.
BDX: 127.93 (+0.71), ALNY: 92.91 (+4.90), PTN: 0.78 (-0.01), HSIC: 130.31 (+8.10)
Will TripAdvisor (TRIP) Beat Q3 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 3:45PM CDT
We expect online travel research company TripAdvisor Inc. (TRIP) to beat expectations when it reports the third-quarter 2014 results on Nov 4.
AMSG: 51.34 (-0.03), TRIP: 74.00 (+2.05), SPR: 40.71 (+0.20), HSIC: 130.31 (+8.10)
Will Priceline.com (PCLN) Disappoint this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 3:44PM CDT
Priceline.com Inc. (PCLN) is set to report the third-quarter 2014 results on Nov 4. Last quarter, the company posted 4.5% positive surprise. Let's see how things are shaping up for this announcement.
AMSG: 51.34 (-0.03), SPR: 40.71 (+0.20), HSIC: 130.31 (+8.10), PCLN: 1,097.75 (+2.41)
Henry Schein's Think Pink, Practice Pink Program Donates More Than $173,000 To Organizations Supporting Cancer-Related Causes In 2014
PR Newswire - Fri Oct 31, 6:00AM CDT
Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today that its "Think Pink, Practice Pink" cause-related marketing program has contributed more than $173,000 to cancer-related causes in 2014.
HSIC: 130.31 (+8.10)
DENTSPLY (XRAY) Beats Q3 Earnings, Misses on Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 3:30PM CDT
DENTSPLY International Inc. (XRAY) reported third-quarter 2014 adjusted earnings of 62 cents per share, which beat the Zacks Consensus Estimate by a couple of cents.
BRLI: 29.19 (-0.23), STE: 62.98 (+0.32), HSIC: 130.31 (+8.10), XRAY: 52.13 (+0.51)
Tornier N.V. (TRNX) Jumps: Stock Moves 7.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 8:46AM CDT
Tornier N.V. (TRNX) was a big mover last session, with shares rising nearly 8% on the day.
CAH: 79.60 (+0.69), TRNX: 25.59 (-0.69), HSIC: 130.31 (+8.10), COO: 166.08 (+1.78)
Heska Signs Distribution Agreement with Henry Schein Animal Health
PR Newswire - Wed Oct 29, 7:45AM CDT
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"
, a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today a new distribution agreement with Henry Schein Animal Health, the largest companion animal health distribution company in the U.S. Henry Schein Animal Health will market and promote Heska's full line of hematology and chemistry instruments and affiliated consumables, effective immediately. HSKA: 15.19 (+0.69), HSIC: 130.31 (+8.10)
Will Cardinal Health (CAH) Disappoint Earnings in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 5:10PM CDT
Our proven model does not conclusively show that Cardinal Health Inc. (CAH) is likely to beat earnings this quarter.
DSCI: 9.00 (+0.05), CAH: 79.60 (+0.69), HTWR: 76.66 (-0.68), HSIC: 130.31 (+8.10)
Will PerkinElmer (PKI) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 4:59PM CDT
PerkinElmer (PKI) has managed to perform decently across several product lines and also posted solid operating results in the previous quarter.
HTWR: 76.66 (-0.68), CRL: 63.73 (+1.05), HSIC: 130.31 (+8.10), PKI: 44.66 (+0.59)
LabCorp Outshines Earnings, Revenues in Q3; Guides Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:30PM CDT
Laboratory Corporation of America Holdings (LH) reported third-quarter 2014 adjusted earnings per share (EPS) of $1.80.
CAH: 79.60 (+0.69), DGX: 62.76 (+2.32), LH: 102.93 (+0.72), HSIC: 130.31 (+8.10)
(0)
(0)Henry Schein Inc. (HSIC) Stock Research Links
Scroll down for more posts ▼